New York 2023-2024 Regular Session

New York Assembly Bill A04804

Introduced
2/23/23  
Refer
2/23/23  

Caption

Requires the brand name of a prescribed drug to be indicated on the label when substitute drug products are dispensed.

Companion Bills

No companion bills found.

Previously Filed As

NY HB1168

Require the dispensing of drugs prescribed for an off-label use during a public health emergency.

NY S07562

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

NY S0482

Amends the types of products which pharmacists may prescribe as substitute drugs or products to include "devices and supplies" and "therapeutically equivalent drugs and pharmaceuticals".

NY H5855

Amends the types of products which pharmacists may prescribe as substitute drugs or products to include "devices and supplies" and "therapeutically equivalent drugs and pharmaceuticals."

NY SB2470

Relating to the requirements for the labeling and dispensing of a prescription drug or biological product.

NY S08285

Requires manufacturers of kratom products within the state to have a warning label that the product has not been approved by the federal food and drug administration and the products' side effects; prohibits labeling of kratom products as all natural.

NY A05852

Requires manufacturers of kratom products within the state to have a warning label that the product has not been approved by the federal food and drug administration and the products' side effects; prohibits labeling of kratom products as all natural.

NY SB716

Relating to off-label indications for prescription drugs; prescribing an effective date.

NY SB355

HIV Prevention Drugs - Prescribing and Dispensing by Pharmacists and Insurance Requirements

NY SB64

HIV Prevention Drugs - Prescribing and Dispensing by Pharmacists and Insurance Requirements

Similar Bills

No similar bills found.